Frederic Daoud This is Me

Education

 Web References

1. 1. More than 1100 Attendees Travel to Barcelona for ISPOR 6th Annual European Congress

   www.ispor.org/news/articles/de - [Cached]

   Published on: 12/27/2002   Last Visited: 8/11/2005

   Jean-Francois Baladi MBA, Frederic Daoud, MD, MSc
   ...
   The session was moderated by Joan Rovira PhD, and featured presentations from Lluis Bohigas MD, from Spain's Ministry of Health, Madrid, Spain, who spoke on "The Role of Government in Medical & Reimbursement Decisions in a Decentralized System"; Antoni Gilabert MD, Head of Pharmaceutical Care & Complimentary Benefits, Catalan Department of Health, Barcelona, Spain, dealing with the topic of "The Role of the Health Systems in the Decision Process in a Decentralized System"; Jean Francois Baladi MBA, Director of Health Policy and Pharmacoeconomics, Novartis Pharma Canada, Inc., Quebec, Canada, who spoke on "Use of Outcomes Research in Pharmaceutical Medical & Reimbursement Decisions in a Decentralized System"; and Frederic Daoud MD, MSc, Epidemiologist Director, Medalliance, Paris, France, who discussed "Use of Outcomes Research in Medical Device & Diagnostic Medical & Reimbursement Decisions in a Decentralized System."

2. 2. EMDM (Editor's Page) - January/February 2003

   www.devicelink.com/emdm/archiv - [Cached]

   Published on: 2/6/2003   Last Visited: 2/6/2003

   The session was chaired by Frederic Daoud, a trained physician and epidemiologist who heads Medalliance Consulting Inc. in Paris, and organized by Management Forum Ltd. (Guildford, Surrey, UK).
   
   "It's easy to understand why payers like case-based hospital funding," noted Daoud in his opening comments. Traditional hospital funding methods tend to be either a global allocation based on "structural" parameters, such as the local population size and the number of hospital beds, or treatment-based payments. These methods lack benchmarks to evaluate a hospital's efficiency, according to Daoud, and they do not establish a budgetary balance between the amount of funding and the hospital's case mix. Treatment-based payments, in particular, can create a perverse incentive to increase spending, because funding is based on the medical services and products required for a procedure, and the number of days a patient is hospitalized. Germany is a case in point.
   
   Currently, German patients enjoy the lengthiest hospital stays in Europe. That will almost surely change when DRGs become mandatory for German hospitals in 2004. While this shift will not lead to a de facto decline in the quality of healthcare, other aspects of the DRG system are troubling to healthcare providers and industry.
   ...
   At the conference, Daoud qualified the Dutch initiative as the "most interesting development in hospital financing in Europe." Given the alternatives, who would disagree?

3. 3. Jacoti Company Information - Medical Device Market Introductions

   www.jacoti.com/info/info.html - [Cached]

   Published on: 6/21/2001   Last Visited: 1/28/2002

   FREDERIC DAOUD, M.D., M.Sc. (Paris).
   
   Qualified epidemiologist.
   
   Several years experience in the medical technology industry.
   
   In charge of various project and business development missions: clinical and cost-effectiveness evaluation studies, European regulatory affairs and reimbursement, market-research and product introduction, customer training, distributor search and technology transfer.
   
   Legal Disclaimer: